|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/69 | |
| A61P 35/00 | |||
| A61K 38/00 | |||
| C12Q 1/68 |
| (11) | Number of the document | 2776043 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12847968.0 |
| Date of filing the European patent application | 2012-11-09 | |
| (97) | Date of publication of the European application | 2014-09-17 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/064496 |
| Date | 2012-11-09 |
| (87) | Number | WO 2013/071142 |
| Date | 2013-05-16 |
| (30) | Number | Date | Country code |
| 201161558474 P | 2011-11-11 | US | |
| 201261721818 P | 2012-11-02 | US |
| (72) |
BERGER, Allison, US
CHATTOPADHYAY, Nibedita, US
KOENIG, Erik, M., US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (54) | BIOMARKERS OF RESPONSE TO PROTEASOME INHIBITORS |
| BIOMARKERS OF RESPONSE TO PROTEASOME INHIBITORS |